首页 | 本学科首页   官方微博 | 高级检索  
     


TIP60 is required for tumorigenesis in non-small cell lung cancer
Authors:Daisuke Shibahara  Naoki Akanuma  Ikei S. Kobayashi  Eunyoung Heo  Mariko Ando  Masanori Fujii  Feng Jiang  P. Nicholas Prin  Gilbert Pan  Kwok-Kin Wong  Daniel B. Costa  Deepak Bararia  Daniel G. Tenen  Hideo Watanabe  Susumu S. Kobayashi
Affiliation:1. Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA;2. Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA

Department of Pathology, University of California San Francisco, San Francisco, California, USA;3. Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA

Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul, South Korea;4. Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Department of Genetics and Genomic Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA;5. Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York, USA;6. Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts, USA;7. Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts, USA

Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore

Abstract:
Keywords:artemisinin  KAT5  lung cancer  TGM5  TIP60
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号